Updated coronavirus vaccines may not be available until mid-September, and people who are not considered high risk may not be able to access them. Coronavirus infections are climbing again, marking another summer wave as children go back to school.

Developers Invivyd, Inc. are working on a plan with the FDA that will see their antibody-based product approved if it passes one more clinical trial.

WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID-19, should get the vaccine, especially.

With Halloween shops opening and pumpkin spice in the air, it’s also time to think about getting a new COVID-19 vaccine for the fall. Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025.

The American Academy of Pediatrics breaks with federal guidance, urging COVID shots for young kids as Kennedy's panel delays vote and stirs backlash.

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 vaccinations, even though the U.S. Department of Health and Human Services no longer recommends that they should.